Quantcast

Latest pharmaceutical industry Stories

2014-09-10 08:32:02

- EMD Serono provides funding for ACP's multicenter longitudinal OPT-UP clinical study ROCKLAND and WALTHAM, Mass., Sept. 10, 2014 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany and the Accelerated Cure Project for Multiple Sclerosis today announced a lead founding sponsor agreement to help launch the Optimizing Treatment--Understanding Progression (OPT-UP) study. http://photos.prnewswire.com/prnvar/20140902/141783...

2014-09-10 08:31:41

Earlier this year upon CFDA approval to the IOPtiMate[TM] system, a strategic distribution agreement was signed with a target of at least 100 systems in China - the world's largest glaucoma markets TEL AVIV, Israel, September 10, 2014 /PRNewswire/ -- BioLight Life Sciences Investments Ltd. (TASE: BOLT, OTCQX:BLGTY), a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, announces the first sale of an IOPtiMate(TM)...

2014-09-10 08:30:43

New addition expands WCG's New England presence and increases its expertise in all phases of clinical research PRINCETON, N.J., Sept. 10, 2014 /PRNewswire/ -- WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services for clinical research, announced today that New England Independent Review Board (IRB) has joined the group of companies. Based near Boston, MA, New England IRB expands WCG's presence in the important New England clinical...

2014-09-10 08:30:06

YARDLEY, Pa., Sept. 10, 2014 /PRNewswire/ -- Since 1974 Mapi has lead Patient-Centred Research and pioneered industry wide innovations in Pharmaceutical Market Research, Cross-Cultural adaptation of Patient Reported Outcomes and Post-Approval pharmaceutical Research. Initiating global programs such as the ERIQA group; launch of the PRO Harmonization Group (which brings together the members of ERIQA, ISOQOL, ISPOR and the 'Health Outcomes Committee' of PhRMA, and the FDA) and...

2014-09-09 16:26:59

CHICAGO, Sept. 9, 2014 /PRNewswire/ -- Pfanstiehl is now making public what many industry experts have suspected was the case ever since the entrepreneurial contract development and manufacturing organization (CDMO) shed its parent firm (Ferro) just over a year ago. The firm is aggressively investing in its potent API contract manufacturing capabilities at its US-based cGMP facility located north of Chicago. This expansion has taken the form of new state of the art equipment,...

2014-09-09 16:26:15

WASHINGTON, Sept. 9, 2014 /PRNewswire-USNewswire/ -- The Parenteral Drug Association (PDA) today announced its plans to publish a Technical Report on the prevention and management of drug shortages. Short supplies and disrupted supply chains of critical, life-saving medicines are becoming an increasing problem for healthcare practitioners and patients in recent years. Regulators in the United States and Europe have been reaching out to industry to find ways to mitigate the kinds of shortages...

2014-09-09 12:30:01

PharmaLex Establishes Affiliated U.S. Pharmaceutical Consulting Group to Provide Client Services Specifically For Food and Drug Administration Requirements MANNHEIM, Germany, Sept. 9, 2014 /PRNewswire-iReach/ -- September 9, 2014 - PharmaLex GmbH (www.pharmalex.com) has announced today that Andrew S. Verderame, MBA, RAC, has joined the company as Senior Advisor. He will establish the PharmaLex U.S. affiliate company and lead business development in the U.S. Mr. Verderame brings a...

2014-09-09 12:29:19

MENLO PARK, Calif., Sept. 9, 2014 /PRNewswire/ -- SRI International, an independent nonprofit research institute, and Nobelpharma, a Japanese pharmaceutical company, have entered into a licensing agreement to test SR16234, an SRI drug candidate that may be effective in treating endometriosis. SR16234 is a member of a class of drugs known as selective estrogen receptor modulators (SERMs) that regulate the effects of the hormone estrogen. "This important collaboration is addressing a...

2014-09-09 12:28:35

PORTLAND, Oregon, September 9, 2014 /PRNewswire/ -- A new report by Allied Market Research, titled "RNA Therapeutics Market (technology, applications, end user and geography) - Industry Analysis and Forecast, 2013 - 2020", suggests that the RNA Based Therapeutics Market would reach $1.2 billion by 2020 registering a CAGR of 28.4% during 2014 - 2020. Due to its ability to render targeted solutions for chronic diseases such as cancer, AIDS, rare genetic disorders, and certain...

2014-09-09 12:28:20

HealthiVibe bridges the gap between clinical trials and patient involvement. The company will present at Disruptive Innovations, September 10 & 12 in Boston. ARLINGTON, Va., Sept. 9, 2014 /PRNewswire/ -- HealthiVibe, LLC, a newly formed company, aims to pioneer a new model in which the patient voice becomes central to clinical trial development. Founded by Abbe Steel, a 23-year veteran of the pharmaceutical industry, HealthiVibe uses a novel approach to gathering patient feedback....


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.